SE0302422D0 - Peptide-based immunization therapy for treatment of atherosclerosis - Google Patents
Peptide-based immunization therapy for treatment of atherosclerosisInfo
- Publication number
- SE0302422D0 SE0302422D0 SE0302422A SE0302422A SE0302422D0 SE 0302422 D0 SE0302422 D0 SE 0302422D0 SE 0302422 A SE0302422 A SE 0302422A SE 0302422 A SE0302422 A SE 0302422A SE 0302422 D0 SE0302422 D0 SE 0302422D0
- Authority
- SE
- Sweden
- Prior art keywords
- peptide
- atherosclerosis
- treatment
- cardiovascular diseases
- immunization therapy
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000002649 immunization Methods 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 title abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 230000000302 ischemic effect Effects 0.000 abstract 2
- 101710095342 Apolipoprotein B Proteins 0.000 abstract 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0012—Lipids; Lipoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0302422A SE0302422D0 (sv) | 2003-09-11 | 2003-09-11 | Peptide-based immunization therapy for treatment of atherosclerosis |
ES04775345T ES2309562T3 (es) | 2003-09-11 | 2004-08-30 | Terapia de inmunizacion basada en peptidos para el tratamiento de la aterosclerosis. |
DK04775345T DK1682578T3 (da) | 2003-09-11 | 2004-08-30 | Peptid-baseret immunoterapi til behandling af åreforkalkning |
AT04775345T ATE396203T1 (de) | 2003-09-11 | 2004-08-30 | Auf peptiden basierende immunisierungstherapie zur behandlung von atheriosclerose |
EP04775345A EP1682578B1 (en) | 2003-09-11 | 2004-08-30 | Peptide-based immunization therapy for treatment of atherosclerosis |
DE602004014012T DE602004014012D1 (de) | 2003-09-11 | 2004-08-30 | Auf peptiden basierende immunisierungstherapie zur behandlung von atheriosclerose |
PCT/SE2004/001239 WO2005023864A1 (en) | 2003-09-11 | 2004-08-30 | Peptide-based immunization therapy for treatment of atherosclerosis |
US11/373,682 US8436139B2 (en) | 2003-09-11 | 2006-03-10 | Peptide-based immunization therapy for treatment of atherosclerosis |
HK06110798A HK1088909A1 (en) | 2003-09-11 | 2006-09-28 | Peptide-based immunization therapy for treatment of atherosclerosis |
US11/875,247 US20080070265A1 (en) | 2003-09-11 | 2007-10-19 | Peptide-based immunization therapy for treatment of atherosclerosis |
US12/262,284 US20090092618A1 (en) | 2003-09-11 | 2008-10-31 | Peptide-based immunization therapy for treatment of atherosclerosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0302422A SE0302422D0 (sv) | 2003-09-11 | 2003-09-11 | Peptide-based immunization therapy for treatment of atherosclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0302422D0 true SE0302422D0 (sv) | 2003-09-11 |
Family
ID=28787306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0302422A SE0302422D0 (sv) | 2003-09-11 | 2003-09-11 | Peptide-based immunization therapy for treatment of atherosclerosis |
Country Status (9)
Country | Link |
---|---|
US (3) | US8436139B2 (sv) |
EP (1) | EP1682578B1 (sv) |
AT (1) | ATE396203T1 (sv) |
DE (1) | DE602004014012D1 (sv) |
DK (1) | DK1682578T3 (sv) |
ES (1) | ES2309562T3 (sv) |
HK (1) | HK1088909A1 (sv) |
SE (1) | SE0302422D0 (sv) |
WO (1) | WO2005023864A1 (sv) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030105003A1 (en) | 2001-04-05 | 2003-06-05 | Jan Nilsson | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
SE0302422D0 (sv) * | 2003-09-11 | 2003-09-11 | Forskarpatent I Syd Ab | Peptide-based immunization therapy for treatment of atherosclerosis |
EP3070477B1 (en) * | 2007-12-05 | 2019-02-20 | The Cleveland Clinic Foundation | Trimethylamine compounds as risk predictors of cardiovascular disease |
CU23736A1 (es) | 2009-05-04 | 2011-11-15 | Centro Inmunologia Molecular | Anticuerpos que reconocen sulfatidos y proteoglicanos sulfatados y su uso |
US8506964B2 (en) | 2010-02-05 | 2013-08-13 | Cardiovax, Llc | Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
CN103608035A (zh) | 2010-11-12 | 2014-02-26 | 赛达斯西奈医疗中心 | 用于治疗和/或预防高血压的免疫调节方法和系统 |
CA2817538A1 (en) | 2010-11-12 | 2012-05-18 | Cedars-Sinai Medical Center | Immunomodulatory methods and systems for treatment and/or prevention of aneurysms |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4970144A (en) * | 1984-12-31 | 1990-11-13 | International Genetic Engineering | Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use |
US5972890A (en) * | 1988-05-02 | 1999-10-26 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
US5408038A (en) * | 1991-10-09 | 1995-04-18 | The Scripps Research Institute | Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides |
DE69332485T2 (de) * | 1992-08-11 | 2003-11-13 | Harvard College | Immunmodulierende peptide |
KR0185334B1 (ko) * | 1995-11-02 | 1999-04-01 | 김은영 | 인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이 |
US6635623B1 (en) * | 1997-06-13 | 2003-10-21 | Baylor College Of Medicine | Lipoproteins as nucleic acid vectors |
US6156315A (en) * | 1997-10-10 | 2000-12-05 | The Trustees Of Columbia University In The City Of New York | Method for inhibiting the binding of low density lipoprotein to blood vessel matrix |
US20030157113A1 (en) * | 1999-12-28 | 2003-08-21 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
SE0000855D0 (sv) * | 2000-03-15 | 2000-03-15 | Karolinska Innovations Ab | Antigenic composition useful as a vaccine against atherosclerosis |
US20030105003A1 (en) * | 2001-04-05 | 2003-06-05 | Jan Nilsson | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
SE0103754L (sv) * | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
US7558611B2 (en) * | 2001-11-24 | 2009-07-07 | Image Analysis, Inc. | Automatic detection and quantification of coronary and aortic calcium |
WO2003087768A2 (en) * | 2002-04-12 | 2003-10-23 | Mitokor | Targets for therapeutic intervention identified in the mitochondrial proteome |
SE0302422D0 (sv) * | 2003-09-11 | 2003-09-11 | Forskarpatent I Syd Ab | Peptide-based immunization therapy for treatment of atherosclerosis |
-
2003
- 2003-09-11 SE SE0302422A patent/SE0302422D0/sv unknown
-
2004
- 2004-08-30 WO PCT/SE2004/001239 patent/WO2005023864A1/en active Application Filing
- 2004-08-30 EP EP04775345A patent/EP1682578B1/en not_active Not-in-force
- 2004-08-30 DK DK04775345T patent/DK1682578T3/da active
- 2004-08-30 DE DE602004014012T patent/DE602004014012D1/de active Active
- 2004-08-30 AT AT04775345T patent/ATE396203T1/de not_active IP Right Cessation
- 2004-08-30 ES ES04775345T patent/ES2309562T3/es active Active
-
2006
- 2006-03-10 US US11/373,682 patent/US8436139B2/en not_active Expired - Fee Related
- 2006-09-28 HK HK06110798A patent/HK1088909A1/xx not_active IP Right Cessation
-
2007
- 2007-10-19 US US11/875,247 patent/US20080070265A1/en not_active Abandoned
-
2008
- 2008-10-31 US US12/262,284 patent/US20090092618A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HK1088909A1 (en) | 2006-11-17 |
ES2309562T3 (es) | 2008-12-16 |
US20090092618A1 (en) | 2009-04-09 |
EP1682578A1 (en) | 2006-07-26 |
US20080070265A1 (en) | 2008-03-20 |
US20060233817A1 (en) | 2006-10-19 |
ATE396203T1 (de) | 2008-06-15 |
DK1682578T3 (da) | 2008-10-27 |
DE602004014012D1 (de) | 2008-07-03 |
EP1682578B1 (en) | 2008-05-21 |
WO2005023864A1 (en) | 2005-03-17 |
US8436139B2 (en) | 2013-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE510851T1 (de) | Auf peptiden basierende immunisierungstherapie zur behandlung von atherosklerose | |
HK1088909A1 (en) | Peptide-based immunization therapy for treatment of atherosclerosis | |
GT200600182A (es) | Anticuerpos dirigidos contra el peptido amiloide beta y metodo que utilizan los mismos | |
NO20083793L (no) | Antistoffer mot amyloid-beta peptid | |
EA200700083A1 (ru) | Антитела, направленные против бета-амилоидного пептида, и способы их применения | |
CO6710903A2 (es) | Un anticuerpo que reconoce y se une específicamente con un fosfo-epítope en la proteína tau de mamífero o en uno de sus fragmentos y una composición comprendiendo el mismo | |
AT500379B8 (de) | Tau-proteine | |
AR033978A1 (es) | Molecula de anticuerpo con especificidad para factor de necrosis tumoral alfa humano y usos de las mismas | |
EA201000809A1 (ru) | АНТИТЕЛА, СПЕЦИФИЧЕСКИЕ В ОТНОШЕНИИ ПРОТОФИБРИЛЛЯРНОЙ ФОРМЫ БЕЛКА β-АМИЛОИДА | |
CY1117387T1 (el) | ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ | |
MA33757B1 (fr) | Protéines de liaison à l'antigène de l'il-23 humaine | |
DE602005027258D1 (de) | Humane monoklonale antikörper gegen hendra- und nipah-viren | |
EA200400162A1 (ru) | N-(3-амино-2-гидроксипропил)замещенные алкиламидные соединения | |
BR0315157A (pt) | Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste | |
EA200801174A1 (ru) | Антитела-миметики glp-2, полипептиды, композиции, способы и применения | |
NO20043891L (no) | Anti-A-beta-antistoffer og deres anvendelse | |
MA28982B1 (fr) | Anticorps antagonistes de il-17 | |
BR0316502A (pt) | Compostos quìmicos | |
MA31899B1 (fr) | Anticorps monoclonaux qui se lient au hgm-csf et compositions medicales les comprenant | |
EA200601946A3 (ru) | Антитела, связывающиеся с белками steap-1, и их производные | |
NO20056055L (no) | Fluorescein-labelled peptides | |
Peng et al. | Targeting a cysteine protease from a pathobiont alleviates experimental arthritis | |
WO2004018511A3 (en) | Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins | |
DE50111112D1 (de) | Hyphenspezifische faktoren aus candida albicans | |
ATE545654T1 (de) | Hyphenspezifische zellwandproteine von candida |